Searched for
MRNA SHOT
Moderna first-quarter revenue jumps on strong overseas COVID vaccine salesModerna's first-quarter revenue surpassed estimates, driven by strong international COVID-19 vaccine sales. The company forecasts lower-tha...- Moderna stocks: MRNA shares jump in US Stock market today after pharma giant surpasses Wall Street estimatesModerna had earlier posted a loss of $2.52 per share a year earlier, while analysts expected a loss of $3.96 per share.
- COVID-19 vaccines may help some cancer patients fight tumorsNew research suggests COVID-19 mRNA vaccines could help cancer patients. Those with advanced lung or skin cancer who received Pfizer or Mod...
- RFK Jr. shocks big pharma, yanks $500 million from mRNA vaccine projects, including for Flu and COVIDUS Health Secretary Robert F. Kennedy Jr. stopped 22 vaccine projects. These projects used mRNA technology. The vaccines aimed to fight COV...
- Sanofi says it's back to the drawing board on mRNA flu vaccinesSanofi, one of the top global vaccine makers, has stated that the current mRNA technology used in COVID-19 vaccines is not effective agains...
- China okays its first mRNA vaccine, from drugmaker CSPCChina, whose home-grown vaccines are seen as less effective than the Moderna and Pfizer-BioNTech mRNA shots, has been racing to develop vac...
- Gennova eyes nod for omicron-specific vaxAs Covid-19 cases saw an uptick in other countries, the government in November approved Bharat Biotech's intranasal vaccine iNCOVACC for he...
- Gennova Biopharmaceuticals developing Omicron specific vaccineGennova Biopharmaceuticals, a subsidiary of Pune-based drugmaker Emcure Pharmaceuticals, is developing a Covid-19 vaccine on its mRNA platf...
- View: To vaccinate the world, we need to look beyond mRNAAccelerating global vaccinations is the only way to ensure we don’t ruin 2022 or 2023 with yet worse variants.
- Can Covid vaccines work as boosters? Here's what researches have to sayIf boosters don’t work well against the variant, vaccine developers will need to make new shots.
- Here’s why developing countries can make COVID-19 mRNA vaccinesDepending on wealthy nations to donate billions of doses is not working, public health experts say. The solution, many now believe, is for ...
- Chinese firm buys Canada mRNA Covid vaccine tech in $500 million dealWhile almost 1 billion people have been fully vaccinated in China, the country is still lacking an mRNA shot, with most of the population i...
- BioNTech shot produces 10x more antibodies than Sinovac: StudyThe research, published in The Lancet, found that antibody levels among Hong Kong health workers who have been fully vaccinated with BioNTe...
- A cure for cancer: After Covid vaccine, next mRNA miracle might be closer than you imagineThe new technology was not only lightning fast but also incredibly effective - mRNA Covid vaccines from both Moderna and Pfizer hit the bul...
- Germany recommends combination of AstraZeneca, mRNA shotsThe committee, known by its German acronym STIKO, didn't detail what studies its conclusion was based on. Germany's disease control center ...
- India's Biological E. to make Providence Therapeutics' mRNA COVID-19 vaccineProvidence will sell up to 30 million doses of its mRNA vaccine, PTX-COVID19-B, to Biological E., and will also provide the necessary techn...
- Are some Covid vaccines working better than others? The jury is outIf this is true, which vaccines a country can secure could affect everything from policy about mask-wearing and social distancing to liftin...
- Countries seek more Moderna, Pfizer/BioNTech shots as concerns mount over rival vaccinesCountries in Europe and Asia, as well as South Africa, are limiting or halting use of AstraZeneca's shot over safety concerns. Rollout of J...
- Pfizer, Moderna COVID-19 vaccines highly effective even after first shot in real-world useThe study by the U.S. Centers for Disease Control and Prevention (CDC) evaluated the vaccines' ability to protect against infection, includ...
- Pfizer to develop new vaccines on its own using mRNA technologyThe drugmaker said it was ready to pursue mRNA on its own following its experience in the past year working on the COVID-19 vaccine, the WS...
Load More
